⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

August 1, 2024Open Access

Supplementary Figure 1 from Molecular Pathways and Cellular Subsets Associated with Adverse Clinical Outcomes in Overlapping Immune-Related Myocarditis and Myositis

Bilal A. Siddiqui Nicolas L. Palaskas Sreyashi Basu Yibo Dai Zhong He Shalini S. Yadav James P. Allison Rahul A. Sheth Sudhakar Tummala L. Maximilian Buja Meenakshi B. Bhattacharjee Cezar Iliescu Anishia Rawther-Karedath Anita Deswal Linghua Wang Padmanee Sharma Sumit K. Subudhi

View Full Paper

Ask AI

Bookmark

Share

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Abstract

Clinical characteristics of patients with confirmed toxicities

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Siddiqui et al. (2024) studied this question.

synapsesocial.com/papers/68e5e0e7b6db6435875752f1 https://doi.org/10.1158/2326-6066.26422562.v1

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Supplementary Figure 1 from Molecular Pathways and Cellular Subsets Associated with Adverse Clinical Outcomes in Overlapping Immune-Related Myocarditis and Myositis2024
2Supplementary Figure 1 from Molecular Pathways and Cellular Subsets Associated with Adverse Clinical Outcomes in Overlapping Immune-Related Myocarditis and Myositis2024
3Supplementary Figure 1 from Molecular Pathways and Cellular Subsets Associated with Adverse Clinical Outcomes in Overlapping Immune-Related Myocarditis and Myositis2024
4Supplementary Figure 17 from Molecular Pathways and Cellular Subsets Associated with Adverse Clinical Outcomes in Overlapping Immune-Related Myocarditis and Myositis2024
5Supplementary Figure 14 from Molecular Pathways and Cellular Subsets Associated with Adverse Clinical Outcomes in Overlapping Immune-Related Myocarditis and Myositis2024

More related papers

Supplementary Figure 14 from Molecular Pathways and Cellular Subsets Associated with Adverse Clinical Outcomes in Overlapping Immune-Related Myocarditis and Myositis2024
Supplementary Figure 14 from Molecular Pathways and Cellular Subsets Associated with Adverse Clinical Outcomes in Overlapping Immune-Related Myocarditis and Myositis2024
Supplementary Figure 13 from Molecular Pathways and Cellular Subsets Associated with Adverse Clinical Outcomes in Overlapping Immune-Related Myocarditis and Myositis2024